Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hunterase (Idursulfase-beta) in Hunter Syndrome Patients <6 Years Receiving Idursulfase ERT
KCT0000567Phase 3Recruiting
- Sponsor
- GC Biopharma
- Start
- Jul 2012
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Idursulfase beta in mucopolysaccharidosis type 2, sponsored by GC Biopharma. Started Jul 2012; status: recruiting.
02
Drugs
Idursulfase beta
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on KCT0000567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000567.